The team building the first two-pressure glaucoma implant.

A US-based, surgeon-led ophthalmic device company.

LIQID Medical was founded to do one thing well: address glaucoma at the mechanism. The company is headquartered in Minneapolis and led by people who have spent careers inside this disease.

Our mission

To prevent blindness from glaucoma by treating the pressure gradient at the optic nerve head, and to partner with the investors, surgeons, and strategics who see the same opportunity.

Headquarters: Minneapolis, Minnesota, United States (est. 2017).

Minneapolis · HQ
Mechanism-led
US clinical pathway

Board of Directors

Governance and clinical leadership spanning glaucoma surgery, device commercialization, and ophthalmic innovation.

Headshot: Dr Daemon McClunan
Dr Daemon McClunan

Founder and CEO

Headshot: John Berdahl, MD
John Berdahl, MD

Director

MD
Headshot: Dick Lindstrom, MD
Dick Lindstrom, MD

Director

MD
Headshot: Rick Beckman, MD
Rick Beckman, MD

Director

MD
Duncan Miller

Director

Sarah Mthintso

Director

Scientific Advisory Board

A senior advisory bench spanning glaucoma surgery, clinical trials, and ophthalmic device commercialization. Named affiliations and institution logos are published as clearances are confirmed.

Headshot: Sanjay Asrani, MD
Sanjay Asrani, MD

Scientific Advisor

MD
Headshot: Keith Barton, MD
Keith Barton, MD

Scientific Advisor

MD
Headshot: Ike Ahmed, MD
Ike Ahmed, MD

Scientific Advisor

MD

Management

A surgeon-founder paired with operators who have built, regulated, and commercialized ophthalmic devices before.

Headshot: Rick Beckman, MD
Rick Beckman, MD

Chief Medical Officer, incoming

CMO
Headshot: Joshua Fischer, PhD
Joshua Fischer, PhD

Chief Operating Officer

COO
Headshot: Lucinda Camras, PhD
Lucinda Camras, PhD

Chief Scientific Officer

CSO
Headshot: Liam Swanepoel, PhD
Liam Swanepoel, PhD

Chief Technology Officer

CTO

Work on something that ends in vision saved.

We hire engineers, clinical researchers, regulatory specialists, and operators who want their craft applied to a problem with a clear human stake. We will read every email.